from Dreamers to Disruptors

a Medidata Podcast

This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors, a Medidata podcast.

Available on:

YoutubeSpotify Spotify Amazon Music

Episode 2
Alzheimer’s Treatments, Dementia Early Detection, and the Future of Central Nervous System Research: Brad O’Connor

As life expectancy increases and survival rates for cancer and heart disease improve, central nervous system (CNS) conditions are increasingly becoming a focus in healthcare. The search to treat Alzheimer’s disease and other forms of dementia grows every day as more people feel their impact.

Cogstate CEO Brad O’Connor has over 20 years of experience driving his company to expand our collective knowledge and ability to detect CNS diseases as we work towards a cure for dementia. He and Medidata CEO Anthony Costello explore this critical and challenging area of clinical research, plus the strides being made to advance it.

Brad shares Cogstate’s work to develop new treatments and reliable, universal tests for assessing changes in cognition. From blood-based biomarkers to AI-powered clinical trials, Brad and Anthony outline a future for people with Alzheimer’s where earlier identification of risk factors leads to longer, happier lives for patients and loved ones.

Episode 1
Women’s Health, Digital Therapeutics, and Driving Change in Pharma: Jessica Federer

As Bayer’s first Chief Digital Officer, Jessica Federer is a true pioneer in life sciences. An early driver of digital transformation in clinical research and a champion for women’s health, she has a unique grasp on the challenges we face, and the opportunities waiting to be realized.

Listen as Medidata CEO Anthony Costello sits down with Jessica to explore her exceptional career, from her work to uplift women’s voices in the industry and tackle gender-based inequalities in healthcare, to the potential of digital therapeutics and other emerging technologies.